======= MIDN ======= == Gene Information == * **Official Symbol**: MIDN * **Official Name**: midnolin * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=90007|90007]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q504T8|Q504T8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MIDN&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MIDN|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606700|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Facilitates ubiquitin-independent proteasomal degradation of polycomb protein CBX4. Plays a role in inhibiting the activity of glucokinase GCK and both glucose-induced and basal insulin secretion. {ECO:0000250|UniProtKB:D4AE48, ECO:0000250|UniProtKB:Q3TPJ7}. No Pfam Domain information is available for this gene. |negative regulation of glucokinase activity| |negative regulation of hexokinase activity| |regulation of glucokinase activity| |regulation of hexokinase activity| |negative regulation of insulin secretion| |negative regulation of cellular carbohydrate metabolic process| |negative regulation of peptide hormone secretion| |negative regulation of carbohydrate metabolic process| |negative regulation of hormone secretion| |kinase binding| |regulation of glucose metabolic process| |negative regulation of protein secretion| |negative regulation of peptide secretion| |regulation of cellular carbohydrate metabolic process| |regulation of insulin secretion| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |negative regulation of secretion by cell| |regulation of carbohydrate metabolic process| |regulation of peptide hormone secretion| |negative regulation of secretion| |negative regulation of kinase activity| |regulation of hormone secretion| |negative regulation of transferase activity| |regulation of small molecule metabolic process| |negative regulation of phosphorylation| |regulation of protein secretion| |negative regulation of transport| |regulation of peptide secretion| |regulation of hormone levels| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |molecular function| |negative regulation of catalytic activity| |regulation of secretion| |nucleolus| |regulation of kinase activity| |regulation of transferase activity| |regulation of protein localization| |negative regulation of molecular function| |negative regulation of cell communication| |negative regulation of signaling| |regulation of phosphorylation| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-3.03| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.52| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.33| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.27| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|-2.03| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.98| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-1.85| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.83| |[[:results:exp211|AICAR 240μM R05 exp211]]|1.71| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|1.71| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|1.71| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|1.72| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|1.73| |[[:results:exp134|MS023 2μM R03 exp134]]|1.79| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|1.85| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|1.87| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.99| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|2.04| |[[:results:exp502|Milciclib 2μM R08 exp502]]|2.52| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|2.55| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.67| |[[:results:exp275|Citral 75μM R06 exp275]]|2.85| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.86| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|2.98| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.99| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|4.12| ^Gene^Correlation^ |[[:human genes:m:mettl3|METTL3]]|0.444| |[[:human genes:c:cd19|CD19]]|0.416| |[[:human genes:m:mapkap1|MAPKAP1]]|0.411| |[[:human genes:p:prkaca|PRKACA]]|0.41| |[[:human genes:r:rhoh|RHOH]]|0.407| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|2/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17723 * **Expression level (log2 read counts)**: 6.09 {{:chemogenomics:nalm6 dist.png?nolink |}}